Calumet Specialty Prods Q2 2024 GAAP EPS $(0.48) Misses $(0.46) Estimate, Sales $1.133B Beat $981.510M Estimate
Portfolio Pulse from Benzinga Newsdesk
Calumet Specialty Products (NASDAQ: CLMT) reported Q2 2024 GAAP EPS of $(0.48), missing the $(0.46) estimate, but achieved sales of $1.133 billion, beating the $981.510 million estimate. EPS decreased by 77.78% year-over-year, while sales increased by 11.30%.
August 09, 2024 | 11:08 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Calumet Specialty Products reported a Q2 2024 GAAP EPS of $(0.48), missing the $(0.46) estimate, but achieved sales of $1.133 billion, beating the $981.510 million estimate. EPS decreased by 77.78% year-over-year, while sales increased by 11.30%.
The mixed earnings report for Calumet Specialty Products shows a significant miss on EPS but a strong beat on sales. The EPS miss and year-over-year decline may concern investors, but the sales beat and growth could provide some optimism. Overall, the short-term impact on the stock price is likely to be neutral as the positive sales performance offsets the negative EPS result.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100